Drug Shortage Report for KAYEXALATE

Last updated on 2019-05-24 History
Report ID 82271
Drug Identification Number 02026961
Brand name KAYEXALATE
Common or Proper name Kayexalate
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) SODIUM POLYSTYRENE SULFONATE
Strength(s) 100%
Dosage form(s) POWDER
Route of administration ORAL RECTAL
Packaging size 1
ATC code V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-04-26
Actual start date
Estimated end date 2019-08-30
Actual end date 2019-05-22
Shortage status Resolved
Updated date 2019-05-24
Company comments Production delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-04-23 English Compare
v2 2019-04-23 French Compare
v3 2019-04-27 English Compare
v4 2019-05-24 English Compare
v5 2019-05-24 French Compare